SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Nuclear EOs: One year later

May 22, 2026, 12:46PMNuclear News

This Saturday, May 23, will mark one year since President Trump issued four executive orders (EOs) that sought to implement sweeping changes across the U.S. nuclear industry. From regulatory...

Dow gets EA/FONSI for Seadrift project

May 20, 2026, 7:18AMNuclear News

At the end of April, TerraPower announced that it had officially begun construction on its Natrium power plant in Kemmerer, Wyo.—one of the two full-scale demonstration projects in the...